InvestSMART

BCAL Diagnostics Limited (ASX: BDX) - Announcements

- Current share price for BDX : $0.060

ASX company news and announcements for BCAL Diagnostics Limited (BDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BCAL Diagnostics Limited (BDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BCAL Diagnostics Limited (BDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BCAL Diagnostics Limited (BDX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$22 Company Presentation - Investor Insights 2 May 2024 1:18PM $0.092 $0.060 fallen by 34.78%
$22 Change in substantial holding 1 May 2024 3:30PM $0.091 $0.060 fallen by 34.07%
$22 Quarterly Activities/Appendix 4C Cash Flow Report 26 Apr 2024 9:26AM $0.095 $0.060 fallen by 36.84%
$22 Initial Director's Interest Notice 3 Apr 2024 7:04PM $0.100 $0.060 fallen by 40%
$22 Ceasing to be a substantial holder 3 Apr 2024 10:45AM $0.100 $0.060 fallen by 40%
$22 Trademark Registrations Received Ahead of Commercial Launch 2 Apr 2024 9:47AM $0.105 $0.060 fallen by 42.86%
$22 Change in substantial holding 27 Mar 2024 11:12AM $0.110 $0.060 fallen by 45.45%
$22 Corporate Presentation 6 Mar 2024 11:01AM $0.090 $0.060 fallen by 33.33%
$22 Appointment of Strategic CEO to Lead Commercial Launch 6 Mar 2024 8:25AM $0.090 $0.060 fallen by 33.33%
$22 Initial Director's Interest Notice 4 Mar 2024 8:12AM $0.090 $0.060 fallen by 33.33%
$22 Final Director's Interest Notice 4 Mar 2024 8:12AM $0.090 $0.060 fallen by 33.33%
$22 BCAL to Host Investor Webcast 1 Mar 2024 10:11AM $0.090 $0.060 fallen by 33.33%
$22 BCAL Strengthens Board with Appointment of Commercial NED 29 Feb 2024 9:40AM $0.090 $0.060 fallen by 33.33%
$22 Cleansing Notice 28 Feb 2024 12:31PM $0.090 $0.060 fallen by 33.33%
$22 Application for quotation of securities - BDX 28 Feb 2024 12:23PM $0.090 $0.060 fallen by 33.33%
$22 Change in substantial holding 27 Feb 2024 6:04PM $0.090 $0.060 fallen by 33.33%
$22 Half Yearly Report and Accounts 20 Feb 2024 5:26PM $0.090 $0.060 fallen by 33.33%
$22 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2024 11:27AM $0.100 $0.060 fallen by 40%
$22 Collaboration with KIMS & Indo-American Hospitals Hyderabad 29 Nov 2023 9:29AM $0.100 $0.060 fallen by 40%
$22 Director Change of Interest Notices X 4 28 Nov 2023 11:53AM $0.100 $0.060 fallen by 40%
$22 Change in substantial holding 28 Nov 2023 11:16AM $0.100 $0.060 fallen by 40%
$22 Cleansing Notice 27 Nov 2023 12:42PM $0.100 $0.060 fallen by 40%
$22 Application for quotation of securities - BDX 27 Nov 2023 12:37PM $0.100 $0.060 fallen by 40%
$22 Application for quotation of securities - BDX 27 Nov 2023 8:12AM $0.100 $0.060 fallen by 40%
$22 Application for quotation of securities - BDX 24 Nov 2023 8:20AM $0.110 $0.060 fallen by 45.45%

151 - 175 of 292 results

Page 7 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.